|
HPRT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65419999984285E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.81980000460536E-08 |
| Normal-vs-Stage2 |
5.796900E-03 |
| Normal-vs-Stage3 |
7.582200E-02 |
| Normal-vs-Stage4 |
9.675900E-02 |
| Stage1-vs-Stage2 |
2.667400E-01 |
| Stage1-vs-Stage3 |
6.219500E-03 |
| Stage1-vs-Stage4 |
7.380000E-02 |
| Stage2-vs-Stage3 |
3.659800E-01 |
| Stage2-vs-Stage4 |
4.895800E-01 |
| Stage3-vs-Stage4 |
9.396600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81459999751377E-08 |
| Normal-vs-AfricanAmerican |
8.434200E-04 |
| Normal-vs-Asian |
8.441800E-01 |
| Caucasian-vs-AfricanAmerican |
1.711180E-01 |
| Caucasian-vs-Asian |
1.824200E-02 |
| AfricanAmerican-vs-Asian |
1.942970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84892118177049E-12 |
| Normal-vs-Female |
1.050820E-01 |
| Male-vs-Female |
3.06190000021189E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.210900E-04 |
| Normal-vs-Extreme_Weight |
2.07789999984165E-07 |
| Normal-vs-Obese |
1.364950E-04 |
| Normal-vs-Extreme_Obese |
5.322800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.675600E-01 |
| Normal_Weight-vs-Obese |
6.895600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.144200E-01 |
| Extreme_Weight-vs-Obese |
4.984600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.708200E-01 |
| Obese-vs-Extreme_Obese |
7.855200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.796600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.91010000044822E-07 |
| Normal-vs-Age(61-80Yrs) |
4.54599999977212E-07 |
| Normal-vs-Age(81-100Yrs) |
2.06209999999984E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.321600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.783700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.003690E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.811800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.203400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.319800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.74835709745958E-12 |
| Normal-VS-Type2 PRCC |
5.27950000051014E-07 |
| Normal-VS-KIRP CIMP |
1.537020E-03 |
| Normal-VS-Unclassified PRCC |
1.841540E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.497200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.66133814775094E-16 |
| Type1 PRCC-VS-Unclassified PRCC |
5.691900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.47150003293461E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
4.345200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.18920000016887E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31539998285513E-09 |
| Normal-vs-N1 |
2.522200E-01 |
| Normal-vs-N2 |
9.422600E-01 |
| N0-vs-N1 |
2.263500E-03 |
| N0-vs-N2 |
4.479100E-03 |
| N1-vs-N2 |
5.898600E-01 |
|
|
